RxDoctor Payments Data

Francis Dooley

Psychiatric/Mental Health · Bronx, NYNPI 1457548257

Payments from drug & device makers

$1,495in general payments, 2019–2025

Across 73 payments — averaging $20.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$350
  • Teva Pharmaceuticals USA, Inc.$337
  • Lundbeck LLC$256
  • Neurocrine Biosciences, Inc.$183
  • Otsuka America Pharmaceutical, Inc.$108
  • Johnson & Johnson$75
  • plus $188 from 7 others

What the payments were for

  • Food & beverage$1,42095%
  • Education$755%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,495 in reported general payments places this provider in the 70th percentile of 2,385 psychiatric/mental health providers in New York.

See all psychiatric/mental health providers in New York

Medicare billing

Part B allowed, 2024
$22,627
Medicare patients
100
Services billed
257

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate14$40,436
RexultiBrexpiprazole17$23,949
Lurasidone Hcl35$13,922
Clozapine47$3,293
Quetiapine Fumarate191$3,093
Aripiprazole79$2,599
Mirtazapine157$2,362
Bupropion XlBupropion Hcl144$2,011
Perphenazine47$1,806
Olanzapine83$1,740
Olanzapine OdtOlanzapine17$1,629
Divalproex Sodium56$1,443
Duloxetine Hcl79$1,360
Clonazepam123$1,343
Doxepin Hcl66$1,230

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$75$40,43614 claims
Otsuka America Pharmaceutical, Inc.Rexulti$108$23,94917 claims
Almatica Pharma LLCSertraline Hcl$13$40297 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,385 psychiatric/mental health providers in New York.

Other psychiatric/mental health in Bronx

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →